𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Symptomatic Hypoglycemia in NIDDM Patients Treated With Oral Hypoglycemic Agents

✍ Scribed by Jennings, A. M.; Wilson, R. M.; Ward, J. D.

Book ID
127244928
Publisher
American Diabetes Association
Year
1989
Tongue
English
Weight
659 KB
Volume
12
Category
Article
ISSN
0149-5992

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hypoglycemia in hospitalized patients tr
Hypoglycemia in hospitalized patients treated with antihyperglycemic agents
✍ Precil Varghese; Vanessa Gleason; Rachel Sorokin; Craig Senholzi; Serge Jabbour; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## OBJECTIVE To determine the incidence and manifestations of hypoglycemia in hospitalized patients receiving antihyperglycemic therapy. ## RESEARCH DESIGN AND METHODS The study was a 3‐month prospective review of consecutive medical records of all adult, nonpregnant hospitalized pat

Effects of a new oral hypoglycaemic agen
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM
✍ B. H. R. Wolffenbuttel; L. Nijst; J. P. J. E. Sels; P. P. C. A. Menheere; P. G. πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 396 KB

We have evaluated the effects of repaglinide, a new non-sulphonylurea oral hypoglycaemic agent that has a stimulatory effect on insulin secretion. Forty-four patients with NIDDM, already treated with a sulphonylurea, took part in an open, randomised, group comparison study of 12 weeks duration, duri